Back to search

Switzerland· 37716022

Novothyral, Tabletten

A kombinationen von levothyroxin und liothyronin product containing levothyroxinum natricum anhydricum, liothyroninum natricum, registered in Switzerland by Merck (Schweiz) AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC H03AA03

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedNovothyral, TablettenATCH03AA03REGISTER NO.37716022PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Kombinationen von levothyroxin und liothyronin is registered in 3 of 19 countries.

Countries holding a registration under ATC H03AA03 (kombinationen von levothyroxin und liothyronin), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 3 of them publish a price we can compare per daily dose

Kombinationen von levothyroxin und liothyronin · ATC H03AA03

3 / 19 countries

  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
levothyroxinum natricum anhydricum, liothyroninum natricum
Manufacturer
Merck (Schweiz) AG
Country
Switzerland (CH)
ATC code
H03AA03
ATC class
Kombinationen von Levothyroxin und Liothyronin
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680377160229
    100 Stk
    CHF 25.55

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

97 interactions on record for kombinationen von levothyroxin und liothyronin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Kombinationen von levothyroxin und liothyronin · interactions on record

97 records

97 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Kombinationen von levothyroxin und liothyronin in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All kombinationen von levothyroxin und liothyronin products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Austria · Novothyral
  • Germany · Novothyral 100, Novothyral 75
  • France · Euthyral
  • Greece · Dithyron
  • Luxembourg · Novothyral 100, Novothyral 75
  • Poland · Novothyral
  • Romania · Novothyral

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3c8131d9-233a-4b5f-a06d-66d80bb9dae1
GET /v1/drugs/3c8131d9-233a-4b5f-a06d-66d80bb9dae1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "levothyroxinum natricum 100 mcg + liothyroninum natricum 20 mcg",
  "valid_from": "1997-03-15",
  "limitations": "[{\"description\":\"Eine Vergütung erfolgt, wenn eine Levothyroxin-Monotherapie nicht zielführend ist oder eine Störung in der Konversion von T4 zu T3 vermutet wird. <br>\\n<br>\\nEine Vergütung erfolgt bei: <br>\\n•   Hypothyreose, wenn das TSH erhöht und fT4 erniedrigt ist.<br>\\n•   subklinischer Hypothyreose (TSH erhöht, fT4 im Referenzbereich) nur wenn TSH ≥ 10 mU/l oder falls TSH < 10m U/l nur nach Erstverschreibung durch eine/n Endokrinologen/Endokrinologin unter Berücksichtigung von anerkannten nationalen resp. internationalen Leitlinien von Fachgesellschaften. <br>\\n•   Frauen mit Infertilität, bei geplanter Schwangerschaft und während der Schwangerschaft: Levothyroxin wird auch bei subklinischer Hypothyreose vergütet. <br>\\n•   den Indikationen ausserhalb der Hypothyreose gemäss Fachinformation.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2025-05-01\"}]",
  "galenic_form": "Tabl",
  "therapeutic_area": null,
  "sl_inclusion_date": "1997-03-15",
  "self_retention_pct": 10
}

See everything about kombinationen von levothyroxin und liothyronin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.